3 recruiting. .
Follow Epiliquid Holding, Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Colon Cancer Liquid Biopsy Investigation of Methylation-based Biomarkers Evaluation Using Delta-HLD (CLIMBED) Colorectal Cancer (CRC) | Recruiting | Epiliquid Holding, Inc | 3200 | 2024-04-04 | 2025-09-11 | |
| Hepatocellular Carcinoma Identification Using Delta-HLD Hepato Cellular Carcinoma (HCC) | Recruiting | Epiliquid Holding, Inc | 200 | 2023-05-18 | 2025-09-09 | |
| Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD Colo-rectal Cancer | Recruiting | Epiliquid Holding, Inc | 600 | 2021-06-30 | 2025-08-29 |
Colorectal Neoplasms (2) · Carcinoma, Hepatocellular (1) · Colonic Neoplasms (1)
Argentina (3)